Towards minimizing immunosuppression in pediatric liver transplant recipients

Pediatric Transplantation

Volumn 13, Issue 5, 2009, Pages 553-559

  Turmelle, Yumirle P ^a,b   Nadler, Michelle L ^a   Anderson, Christopher D ^a,b   Doyle, Maria B ^b   Lowell, Jeffrey A ^a,b   Shepherd, Ross W ^a,b  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunosuppression; Liver transplant; Outcome; Pediatric

Indexed keywords

ACICLOVIR; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RITUXIMAB; STEROID; TACROLIMUS; VALGANCICLOVIR;

ADJUVANT THERAPY; ARTICLE; BILE DUCT ATRESIA; CHILD; CHILD GROWTH; CHRONIC GRAFT REJECTION; CYTOMEGALOVIRUS INFECTION; DATA BASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVER TUMOR; LONG TERM CARE; LOW DRUG DOSE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION SYSTEM; MONOTHERAPY; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PEDIATRIC SURGERY; POSTOPERATIVE CARE; VIRUS INFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER DISEASES; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; PROSPECTIVE STUDIES; STEROIDS; TREATMENT OUTCOME;

EID: 67651171564     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01061.x     Document Type: Article

References (38)

1. Martin SR, Atkison P, Anand R, Lindblad AS, SPLIT Research Group. Studies of Pediatric Liver Transplantation 2002: Patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant 2004 : 8 : 273 283.
2. McDiarmid SV. Current status of liver transplantation in children. Pediatr Clin North Am 2003 : 50 : 1335 1374.
3. SPLIT Research Group. Studies of Pediatric Liver Transplantation (SPLIT): Year 2000 outcomes. Transplantation 2001 : 72 : 463 476.
4. Jain A, Mazariegos G, Kashyap R, et al. Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation 2002 : 73 : 941 947.
5. Cacciarelli TV, Reyes J, Jaffe R, et al. Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients. Pediatr Transplant 2001 : 5 : 359 364.
6. Shepherd RW, Turmelle Y, Nadler M, et al. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant 2008 : 8 : 396 403.
7. Bishop GA, McCaughan GW. Immune activation is required for the induction of liver allograft tolerance: Implications for immunosuppressive therapy. Liver Transpl 2001 : 7 : 161 172.
8. Mazariegos GV, Sindhi R, Thomson AW, Marcos A. Clinical tolerance following liver transplantation: Long term results and future prospects. Transpl Immunol 2007 : 17 : 114 119 Epub. Oct. 17 2006.
9. Koshiba T, Li Y, Takemura M, et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol 2007 : 17 : 94 97 Epub. Nov. 10 2006.
10. Starzl TE. Chimerism and tolerance in transplantation. Proc Natl Acad Sci USA 2004 : 101 (Suppl. 2 14607 14614 Epub. Aug. 19 2004.
11. Miller J, Mathew JM, Esquenazi V. Toward tolerance to human organ transplants: A few additional corollaries and questions. Transplantation 2004 : 77 : 940 942.
12. Fan X, Ang A, Pollock-Barziv SM, et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 2004 : 10 : 1227 1233 Epub. Oct. 24 2004.
13. McDiarmid SV, Ettenger RB, Fine RN, Busuttil RW, Ament ME. Serial decrease in glomerular filtration rate in long-term pediatric liver transplantation survivors treated with cyclosporine. Transplantation 1989 : 47 : 314 318.
14. Gupta P, Hart J, Cronin D, Kelly S, Millis JM, Brady L. Risk factors for chronic rejection after pediatric liver transplantation. Transplantation 2001 : 72 : 1098 1102.
15. Farmer DG, Venick RS, McDiarmid SV, et al. Predictors of outcomes after pediatric liver transplantation: An analysis of more than 800 cases performed at a single institution. J Am Coll Surg 2007 : 204 : 904 914.
16. Diem HV, Sokal EM, Janssen M, Otte JB, Reding R. Steroid withdrawal after pediatric liver transplantation: A long-term follow-up study in 109 recipients. Transplantation 2003 : 75 : 1664 1670.
17. Jain A, Mazariegos G, Kashyap R, et al. Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation. Pediatr Transplant 2001 : 5 : 93 98.
18. Bourdeaux C, Darwish A, Jamart J, et al. Living-related versus deceased donor pediatric liver transplantation: A multivariate analysis of technical and immunological complications in 235 recipients. Am J Transplant 2007 : 7 : 440 447 Epub. Dec. 6 2006.
19. Cao S, Cox KL, Berquist W, et al. Long-term outcomes in pediatric liver recipients: Comparison between cyclosporin A and tacrolimus. Pediatr Transplant 1999 : 3 : 22.
20. Cho JH, Bhatnagar V, Andreani P, et al. Chronic rejection in pediatric liver transplantation. Transplant Proc 1997 : 29 : 452.
21. Soltys KA, Mazariegos GV, Squires RH, Sindhi RK, Anand R, SPLIT Research Group. Late graft loss or death in pediatric liver transplantation: An analysis of the SPLIT database. Am J Transplant 2007 : 7 : 2165 2171.
22. Cintorino D, Riva S, Spada M, et al. Corticosteroid-free immunosuppression in pediatric liver transplantation: Safety and efficacy after a short-term follow-up. Transplant Proc 2006 : 38 : 1099 1100.
23. Lee TC, Savoldo B, Rooney CM, et al. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant 2005 : 5 : 2222 2228.
24. Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Pediatr Transplant 2004 : 8 : 267 272.
25. Guthery SL, Heubi JE, Bucuvalas JC, et al. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment. Transplantation 2003 : 75 : 987 993.
26. Renz JF, de Roos M, Rosenthal P, et al. Posttransplantation growth in pediatric liver recipients. Liver Transpl 2001 : 7 : 1040 1055. (Pubitemid 34023991)
27. McDiarmid SV, Gornbein JA, DeSilva PJ, et al. Factors affecting growth after pediatric liver transplantation. Transplantation 1999 : 67 : 404 411.
28. Bartosh SM, Thomas SE, Sutton MM, Brady LM, Whitington PF. Linear growth after pediatric liver transplantation. J Pediatr 1999 : 135 : 624 631.
29. Wheatley HC, Datzman M, Williams JW, et al. Long-term effects of cyclosporine on renal function in liver transplant recipients. Transplantation 1987 : 43 : 641 647.
30. Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003 : 9 : 741 747.
31. Distant DA, Gonwa TA. The kidney in liver transplantation. J Am Soc Nephrol 1993 : 4 : 129 136.
32. Gonwa TA, Morris CA, Goldstein RM, et al. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome - experience in 300 patients. Transplantation 1991 : 51 : 428 430.
33. Fung JJ, Alessiani M, Abu-Elmagd K, et al. Adverse effects associated with the use of FK 506. Transplant Proc 1991 : 23 : 3105 3108.
34. Berg UB, Ericzon BG, Nemeth A. Renal function before and long after liver transplantation in children. Transplantation 2001 : 72 : 631 637. (Pubitemid 32802744)
35. Evans GO, Griffiths PD. Limitations concerning the use in children of the relationship between plasma creatinine and body height to derive glomerular filtration rate. Ann Clin Biochem 1981 : 18 : 295 298.
36. Campbell KM, Yazigi N, Ryckman FC, et al. High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation. J Pediatr 2006 : 148 : 475 480.
37. Arora-Gupta N, Davies P, McKiernan P, Kelly DA. The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation. Pediatr Transplant 2004 : 8 : 145 150.
38. Wiesmayr S, Jungraithmayr TC, Ellemunter H, et al. Long-term glomerular filtration rate following pediatric liver transplantation. Pediatr Transplant 2005 : 9 : 604 611.